» Authors » Brian Harris

Brian Harris

Explore the profile of Brian Harris including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 273
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Judge L, Bellar D, Blom L, Lee D, Harris B, Turk M, et al.
J Strength Cond Res . 2012 Mar; 26(4):1154-61. PMID: 22446680
Injuries suffered by student athletes not only affect their physical ability to perform in sport but also have psychological effects as well. The purpose of this study was to examine...
12.
Kahn J, Muraguri N, Harris B, Lugada E, Clasen T, Grabowsky M, et al.
PLoS One . 2012 Feb; 7(2):e31316. PMID: 22347462
Background: Efficiently delivered interventions to reduce HIV, malaria, and diarrhea are essential to accelerating global health efforts. A 2008 community integrated prevention campaign in Western Province, Kenya, reached 47,000 individuals...
13.
Kahn J, Harris B, Mermin J, Clasen T, Lugada E, Grabowksy M, et al.
BMC Health Serv Res . 2011 Dec; 11:346. PMID: 22189090
Background: Delivery of community-based prevention services for HIV, malaria, and diarrhea is a major priority and challenge in rural Africa. Integrated delivery campaigns may offer a mechanism to achieve high...
14.
Fernandez P, Trenholme A, Abarca K, Griffin M, Hultquist M, Harris B, et al.
BMC Pediatr . 2010 Jun; 10:38. PMID: 20525274
Background: Respiratory syncytial virus (RSV) is an important pathogen causing annual epidemics of bronchiolitis and pneumonia among infants worldwide. High-risk infants currently receive RSV prophylaxis with palivizumab, a humanized RSV...
15.
Carbonell-Estrany X, Simoes E, Dagan R, Hall C, Harris B, Hultquist M, et al.
Pediatrics . 2009 Dec; 125(1):e35-51. PMID: 20008423
Objective: Palivizumab reduces respiratory syncytial virus (RSV) hospitalization in children at high risk by approximately 50% compared with placebo. We compared the efficacy and safety of motavizumab, an investigational monoclonal...
16.
Abarca K, Jung E, Fernandez P, Zhao L, Harris B, Connor E, et al.
Pediatr Infect Dis J . 2009 Mar; 28(4):267-72. PMID: 19258920
Background: : Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infection in young children. Motavizumab is an investigational humanized monoclonal antibody for RSV prophylaxis. Methods: :...
17.
Harris B, Lazarus J
Lancet . 2004 Jun; 363(9426):2092. PMID: 15207976
No abstract available.
18.
Oretti R, Harris B, Lazarus J, Parkes A, Crownshaw T
Int J Soc Psychiatry . 2003 Jun; 49(1):70-6. PMID: 12793517
Background: Postnatal depression is more common in women positive for thyroid autoantibodies, independent of thyroid hormone dysfunction, but the basis of this association is unclear. Aims: The objective of the...
19.
Harris B, Oretti R, Lazarus J, Parkes A, John R, Richards C, et al.
Br J Psychiatry . 2002 Apr; 180:327-30. PMID: 11925355
Background: Women who are positive for thyroid antibodies in early gestation are prone to post-partum depression, apparently independent of thyroid dysfunction, as measured by serum levels of free thyroxine, free...